January 10, 2018 / 6:43 AM / 9 months ago

BRIEF-Gensight Biologics Obtains Authorization Of Mhra To Start Clinical Study Of Phase I/II Pioneer Of Gene Therapy GS030‍​

Jan 10 (Reuters) - GENSIGHT BIOLOGICS SA:

* GENSIGHT OBTAINS AUTHORIZATION OF MHRA TO START CLINICAL STUDY OF PHASE I/II PIONEER OF GENE THERAPY GS030‍​

* EXPECTS TO TREAT FIRST PATIENT IN UK IN Q1 2018‍​‍​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below